Aug 7 (Reuters) – Sino Biopharmaceutical Limited: * NMPA APPROVES BENMELSTOBART WITH CHEMOTHERAPY FOLLOWED BY ANLOTINIB FOR FIRST-LINE SQ-NSCLC Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
SPANISH GOVERNMENT SAYS PASSPORT AND NATIONALITY CHECKS ON ITALIAN PASSENGERS WILL START FROM MIDNIGHT ON…
US sanctions Dubai crypto exchange for aiding Iran's IRGC, following a Reuters report
Aug 7 (Reuters) - The United States on Friday sanctioned an unlicensed multi-state cryptocurrency exchange,…
Canada discussing trade concessions with US to avoid new tariffs, says source
By David Ljunggren OTTAWA, Aug 7 (Reuters) - Canada and the U.S. are discussing a…
